Ensysce Biosciences ENSC
NASDAQ ENSC
$0.41 +0.01 (+1.71%)
As of: Oct 2, 2026 · 10:45 AM EDT

Ensysce Biosciences (ENSC) Non Operating Interest Expenses (2020 - 2025)

Updated

Ensysce Biosciences' Non Operating Interest Expenses was -$992.00 in Q4 2025, compared with $10,753 a year earlier.

Analysis

Ensysce Biosciences (ENSC) Non Operating Interest Expenses (2020 - 2025) Analysis & Trends

For FY2025, Non Operating Interest Expenses at Ensysce Biosciences came in at $12,393, down 99.0% from FY2024.

  • Non Operating Interest Expenses shows a five-year compound annual growth rate of -58.4% (FY2020 to FY2025).
  • In earlier years, Non Operating Interest Expenses was $1.29 million in FY2024 (+264.6%), $353,945 in FY2023 (+223.2%), $109,525 in FY2022 (-91.5%) and $1.3 million in FY2021 (+30.1%).
  • The Q4 2025 figure marks the lowest quarterly Non Operating Interest Expenses in data going back to Q1 2020.
  • Compared with a year earlier, Non Operating Interest Expenses was higher in 1 of the last five quarters, with an average decline of 55.0%.
  • The best year-over-year quarter for Non Operating Interest Expenses over five years was Q4 2023 (growth of 564.8%); the worst was Q1 2025 (a decline of 99.7%).
  • Per Business Quant data, ENSC's Non Operating Interest Expenses in the three quarters before Q4 2025 was $6,369 (Q3 2025), $3,160 (Q2 2025) and $3,856 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Ensysce Biosciences 1.07 Mn -10.50 Mn - -992.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -992.00
Sep 30, 2025 6,369.00
Jun 30, 2025 3,160.00
Mar 31, 2025 3,856.00
Dec 31, 2024 10,753.00
Sep 30, 2024 4,063.00
Jun 30, 2024 27,563.00
Mar 31, 2024 1.25 Mn
Dec 31, 2023 344,799.00
Sep 30, 2023 7,649.00
Mar 31, 2023 1,497.00
Dec 31, 2022 51,863.00
Sep 30, 2022 4,859.00
Jun 30, 2022 37,781.00
Mar 31, 2022 15,021.00
Dec 31, 2021 12,487.00
Sep 30, 2021 24,660.00
Jun 30, 2021 910,327.00
Mar 31, 2021 347,834.00
Dec 31, 2020 247,966.00
API Access

Ensysce Biosciences Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ENSC&period=max&api_key=YOUR_API_KEY